Aaron Levitt

Aaron Levitt

Aaron Levitt is an independent investment analyst and author living in State College, Pennsylvania. His work appears in several high profile publications in both print and on the web.

As an advocate for long-term globally oriented investing, Aaron believes that exchange traded funds have leveled playing field for Main Street. Following global macro-economic trends, investors now have several avenues to create great long term portfolios.

Aaron is a graduate of The Pennsylvania State University where he studied Economics and International Business. Aside for helping regular investors develop winning portfolios, his current projects include writing his first book on alternative energy investing.

Follow his picks and pans on Twitter at @AaronLevitt.

Recent Articles

5 Top-Notch Dividend ETFs That Investors Should Consider Today

Dividend ETFs are still one of the best ways to score income in your portfolio. Here are five top-notch dividend ETFs to buy today.

The Turnaround Is Working at Kinder Morgan

Three years ago, oil stocks were crashing and KMI was tanking. Now it's a different story. Kinder Morgan is finally on the right path again and getting stronger. That's great news for dividend-seekers.

5 MedTech Stocks That Perfectly Blend Healthcare and Technology

MedTech Stocks are hot, hot, hot. Here are five of the best to buy today for long-term growth.

Freeport-McMoRan Reaches Agreement, But It’s Not What Investors Wanted

Freeport-McMoRan's deal isn't exactly great news for shares. FCX stock could feel the effects for years to come.

Prime Day Doesn’t Really Matter for Amazon, but It’s Nice

Amazon Prime Day is coming. But it doesn't matter too much for AMZN stock. Amazon Prime Day is the icing on the cake and the cake itself is already pretty sweet. That’s because AMZN is already dominating the e-commerce world.

5 Gold Stocks to Buy if a Bottom Is In

Precious metals may have bottomed. That means the gold stocks are on the menu once again. Here are five to buy today to play the reversal.

5 Biotech Stocks That Could Be the Next Amgen

Looking for the next big biotech stock? Skip the clinical ones and focus on those with approved drugs. Here are 5 biotech stocks to buy today.

Stick with Refiners and Wait for the OPEC Decision to Shake Out

Who could win from the latest moves at OPEC? The refiners of course!

Build a Total Portfolio With Just 5 Vanguard ETFs

Want to build a diversified portfolio? Vanguard ETFs make that process easy. Here are 5 great core choices.

Investors Should Follow Buffett Into Phillips 66 Stock

Warren Buffett loves Phillips 66, and investors should too. PSX stock remains a cash and dividend machine.